4d Molecular Therapeutics Stock Analysis

FDMT Stock Analysis Notes

About 96.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 0.66. Some equities with similar Price to Book (P/B) outperform the market in the long run. 4D Molecular Therapeutics recorded a loss per share of 2.85. The entity had not issued any dividends in recent years. 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. The company was founded in 2013 and is headquartered in Emeryville, California. 4D Molecular operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 138 people. To learn more about 4D Molecular Therapeutics call David MD at 510 505 2680 or check out https://www.4dmoleculartherapeutics.com.

4D Molecular Therapeutics Investment Alerts

4D Molecular Therapeutics Upcoming and Recent Events

FDMT Largest EPS Surprises

View All Earnings Estimates

4D Molecular Environmental, Social, and Governance (ESG) Scores

FDMT Stock Institutional Investors

Note, although 4D Molecular's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

FDMT Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 363.81 M.

FDMT Profitablity

Management Efficiency

4D Molecular Therapeutics has return on total asset (ROA) of (0.1686) % which means that it has lost $0.1686 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2406) %, meaning that it created substantial loss on money invested by shareholders. 4D Molecular's management efficiency ratios could be used to measure how well 4D Molecular manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.31 in 2024. Return On Capital Employed is likely to drop to -0.37 in 2024. At this time, 4D Molecular's Liabilities And Stockholders Equity is comparatively stable compared to the past year. Change To Liabilities is likely to gain to about 800.4 K in 2024, whereas Total Current Liabilities is likely to drop slightly above 14.9 M in 2024.

Technical Drivers

As of the 30th of November, 4D Molecular owns the Variance of 16.71, information ratio of (0.26), and Market Risk Adjusted Performance of 1.69. 4D Molecular Therapeutics technical analysis gives you the methodology to make use of past data patterns to determine a pattern that approximates the direction of the firm's future prices.

4D Molecular Therapeutics Price Movement Analysis

4D Molecular Therapeutics Insider Trading Activities

4D Molecular Outstanding Bonds

4D Molecular Predictive Daily Indicators

4D Molecular Corporate Filings

4D Molecular Forecast Models

4D Molecular's time-series forecasting models are one of many 4D Molecular's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary 4D Molecular's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how 4D Molecular prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling FDMT shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as 4D Molecular. By using and applying FDMT Stock analysis, traders can create a robust methodology for identifying FDMT entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. FDMT analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. FDMT analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

4D Molecular Therapeutics stock analysis indicators help investors evaluate how 4D Molecular stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading 4D Molecular shares will generate the highest return on investment. By understating and applying 4D Molecular stock analysis, traders can identify 4D Molecular position entry and exit signals to maximize returns.

When running 4D Molecular's price analysis, check to measure 4D Molecular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 4D Molecular is operating at the current time. Most of 4D Molecular's value examination focuses on studying past and present price action to predict the probability of 4D Molecular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 4D Molecular's price. Additionally, you may evaluate how the addition of 4D Molecular to your portfolios can decrease your overall portfolio volatility.